Cumberland Partners LTD Amgen Inc Transaction History

Cumberland Partners LTD

$1.33 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $915,406 - $1.03 Million	3,580 New	3,580 $1.03 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $14,657 - $18,624	-64 Reduced 0.65%	9,828 $2.58 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2.26 Million - $2.51 Million	9,792 Added 9792.0%	9,892 $2.41 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $21,927 - $24,257	100 New	100 $24,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $1.74 Million - $2.03 Million	-8,177 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $893,910 - $991,728	3,827 Added 87.98%	8,177 $1.99 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $948,221 - $1.1 Million	-4,273 Reduced 49.55%	4,350 $1.08 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $5,193 - $6,184	24 Added 0.28%	8,623 $1.98 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $657,020 - $730,660	2,800 Added 48.28%	8,599 $2.19 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $608,265 - $746,425	-3,075 Reduced 34.65%	5,799 $1.37 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $610,504 - $809,695	3,350 Added 60.64%	8,874 $1.8 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $2,089 - $2,503	-12 Reduced 0.22%	5,524 $1.07 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $167,700 - $196,582	1,006 Added 22.21%	5,536 $1.02 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $150,302 - $169,424	831 Added 22.47%	4,530 $860,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $410,320 - $478,975	-2,300 Reduced 38.34%	3,699 $720,000
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $217,715 - $245,445	1,175 Added 24.36%	5,999 $1.24 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $801,025 - $899,724	4,824 New	4,824 $891,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.

Account